By Charles Simengwa –

RESULTS from the latest and second scientific research on the Tian Immune Booster (TIB) products conducted at the University of Namibia offer more accumulated evidence of the enduring potency of what, over the years, has become known as the ‘wonder drug’.
The report by Dr Petrina Kapewangolo, which came out on December 2, 2016, shows that TIB drugs have the ability to inhibit the replication of HIV.
The results of the protease inhibition assays particularly conducted in November 2016 indicate that two of the TIB products recorded a 100 per cent pass in suppressing HIV viral replication.
Apart from this, the most important thing is that there were the fusion assays which confirmed TIB products being the fusion inhibitor done in Germany and Japan 13 years ago.

SHENGXUN

A growing number of AIDS patients continue to find new hope for a prolonged life through TIB, invented by Tian Shengxun, who is based in Nairobi, Kenya, and has been a medical practitioner from 1982 when he completed university studies.
TIB, which has been registered by the Pharmacy and Poisons Board under the Ministry of Health in Kenya, is working wonders in people living with HIV/AIDS, including in anti-retroviral therapy (ART) failure cases.
Patients can take both TIBs and ARVs if they opt to do so.
It is, therefore, not surprising that traditional Chinese medicines have been widely recognised and are being used side-by-side with conventional medicines.
This is a fact that countries around the globe, more so in low economies, can no longer mask as the hope in AIDS patients is increasingly kindled by such drugs as TIB.
Professor Tian, who was first sent to Zambia as part of a Chinese medical expert team in 1990, has been using TIB to treat complicated diseases such as heart, kidney and liver problems, tumour, and anaemia with remarkable outcomes.
The Tian Immunity Booster is a 100 per cent extraction of herbs manufactured in tablet or capsule form.
The drug has been granted international invention patent certificates from China, Africa and the European Union (EU).
It comprises pure herbal products with sugar-coated tablets whose active ingredients are extracted from 100 per cent herbs using modern technology.
The laboratory results at Freiburg University in Germany and Tokyo Japan indicated
that TIB is capable of stopping the fusion between the CD4 cells and HIV from taking place.
Professor Tian said TIB is of multiple targets to control viral load.
It particularly blocks the fusion taking place between the HIV and CD4 cells, which implies that it can stop HIV from infecting the CD4 cells being fusion inhibitor.
TIB has proved to be useful in tackling opportunistic infections such as tuberculosis (TB), and even multi-drug resistant tuberculosis (MDR-TB), which is a global threat.
The fusion inhibitor function makes TIB products unique fighters against HIV/AIDS.
The products have multiple functions with multiple targets to kill HIV through the blocking fusion taking place between the HIV and T-cell, which is the CD4 cell with CCR5 and CXCR4 and suppress the replication of HIV at the same time.
“So TIB products can be used at any stage of HIV infection and the earlier one starts the TIB combination therapy, the better,” said Professor Tian.
He indicated that another key point of TIB drugs is that they are a wide brand of antibiotics and an amazing immunity booster without any side effects and toxicity.
“This is the crucial base of TIBs to fight HIV/AIDS successfully clinically,” he said.
TIB therapy – which is both a fusion inhibitor and enzyme inhibitor (RT and PI) – can offer a solution to AIDS patients, and most of the patients who are taking TIB products can achieve functional cure after about 12-month treatment.
It is no wonder then that most of Professor Tian’s patients have depended on the TIB combination therapy from way before the year 2000.
This further attests to the fact that traditional Chinese medicines (TCMs) have made notable contributions to the improvement of local health conditions in African countries from the 1960s.
Professor Tian says patients on conventional ARVs should religiously take them without any slip-ups, failure to which it will result in health problems.
A point of note is that people can stop taking TIB any time and resume taking it any time.
According to Professor Tian, TIB comprises pure herbal products with sugar-coated tablets whose active ingredients are extracted from 100 per cent herbs.
It blocks the fusion taking place between the HIV and CD4 cells, which implies that it can stop HIV from infecting the CD4 cells.
Herbal drugs are not only benefitting AIDS patients, but they are also giving relief to African governments that are committing colossal amounts of money to health budgets due to a high disease burden.
One could cite MDR-TB which threatens to kill 75 million people by the year 2050, costing US$16.7 trillion, and is the equivalent of the EU’s annual output, according to a UK parliamentary group.
TIB is certainly playing a pivotal role in answering the HIV/AIDS puzzle, and providing relief to many patients.